Yesterday 8 Companies Raised a Total of $267 Million.
Azteco, Kelvin, Paradromics, Instawork, Myeloid Therapeutics, FLINTpro, Hallow, and Lumeus.ai announced funding rounds.
Interested in human due diligence services for your investment firm? Visit our website to learn more and connect with us today!
Deal #1: Azteco Raises $6 million in Seed Funding
About:
Azteco simplifies the process of obtaining Bitcoin, so that anyone anywhere can understand it and use it. The Azteco solution is a merchant platform where vendors can sell Bitcoin through a system of familiar and simple to use 16 digit voucher codes. Simple to use retail Bitcoin is the missing link to where Bitcoin will sweep across the entire
globe. It is the final step that will onboard billions of people to global e-commerce -- Azteco addresses this market perfectly.
Funding Round Info:
Azteco, a Santa Monica, CA-based provider of vouchers for small amounts of bitcoin for everyday use, raised $6M in Seed funding. The round was led by Jack Dorsey, with participation from Lightning Ventures, Hivemind Ventures, Ride Wave Ventures, Aleka Capital, Visary Capital, Gaingels, David Van Der Weele and Sunil Rajaraman. The company intends to use the funds for product development and market expansion in Latin America and Europe.
Thanks for reading Private Market Roundup! Subscribe for free to receive new posts and support our work.
Deal #2: Kelvin Raises $30 million in Series A Funding
About:
Kelvin is an energy management and electrification platform for radiator heated buildings. The Radiator Labs system uses smart thermostatic radiator enclosures (Cozys) networked to central heating controls to eliminate fuel waste, reduce building emissions, and improve tenant comfort. Our hybrid electrification platform enables buildings to electrify 60-80% of their space-heating requirements for 20% of the cost of typical electrification alternatives. Buildings outfitted with the Radiator Labs Hybrid Electrification technology can be programmed to optimize heating fuel sources based on energy pricing, building energy letter grades, and carbon fines. The Radiator Labs hybrid electrification technology would enable all radiator heated buildings to meet NYC 2030 emission caps at a significantly reduced cost. Radiator Labs' technology has been validated by NYSERDA to save 25.5%, on average, in heating costs and was included in the 2019 New York State Technical Resource Manual (TRM). Radiator Labs is a recipient of the 2012 MIT Clean energy prize, the 2014 Popular Science Innovation Award, the 2014 Verizon Powerful Answers award, the 2017 Architizer A+ Award, The 1776 Challenge Cup, and the 2020 New York City Department of Buildings Carbon Neutrality Innovation Challenge. Radiator Labs is also a member of the inaugural cohort of The Clean Fight, powered by NYSERDA and the New Energy Nexus. Radiator Labs was founded in 2011 and is based in Brooklyn, New York.
Funding Round Info:
Kelvin (formerly know as Radiator Labs), a New York-based provider of decarbonized HVAC solutions for legacy buildings, raised $30M in Series A funding. The round was led by 2150, with participation from the Schmidt Family Foundation, the Partnership Fund for NYC. The company intends to use the funds to hire talent and build a scalable platform for accelerating the adoption of economically and environmentally sustainable HVAC options worldwide.
Deal #3: Paradromics Raises $33 Million in Funding, Achieves Breakthrough Medical Device Designation from FDA
About:
Paradromics is bringing to market the first high data rate interface between brains and computers to create a new industry where medical challenges are met with technical solutions.
Funding Round Info:
Paradromics Inc., a leading developer of high data-rate brain-computer interfaces (BCI), has successfully raised $33 million in a Series A funding round led by Prime Movers Lab. The funding round also saw participation from notable investors such as Westcott Investment Group, Dolby Family Ventures, and Green Sands Equity. The newly secured funds will enable Paradromics to initiate its first-in-human clinical trial for the Connexus® Direct Data Interface (DDI). In a significant development, Paradromics announced that the U.S. Food and Drug Administration (FDA) has granted the Connexus DDI the coveted “Breakthrough Device Designation.” This designation signifies the FDA’s recognition of the transformative potential of the device in treating irreversibly debilitating conditions and provides an expedited review process for such groundbreaking medical devices.
Deal #4: Instawork Raises $60M to Invest in AI Technology
About:
Instawork operates as a career marketplace for hospitality professionals. It is changing how traditional recruiting works for small businesses by turning the process into an automated matching solution. Its vision is to create economic opportunity for local businesses and professionals, globally.
The company was founded in 2015 and is
headquartered in San Francisco, California.
Funding Round Info:
Instawork, the leading platform connecting businesses with skilled hourly workers, has successfully raised $60 million in a Series D funding round. The round was led by TCV, with participation from new investors 9Yards Capital and Larry Fitzgerald Jr., as well as existing investors including Benchmark, Spark Capital, Craft Ventures, and Greylock. With this latest investment, Instawork’s total funding now amounts to $160 million, enabling the company to further enhance its AI-powered mobile app and platform. This platform serves as a connection point for over 4 million skilled hourly workers and tens of thousands of businesses.
Deal #5: Myeloid Therapeutics Announces $73 Million Financing to Advance mRNA-based Immunotherapy Pipeline
About:
Myeloid Therapeutics is an immunology company focused on combining immunologic insights with cutting-edge technologies to harness myeloid cells to eradicate cancer and other diseases. The Company's ATAKTM platform technology can be broadly applied, and it is initially advancing a cell therapy program for T cell lymphoma and a primed monocyte
approach to treat glioblastoma. The ATAK platform is scalable to multiple treatment modalities and other disease areas in collaboration with partners.
Funding Round Info:
Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage mRNA-immunotherapy company, announced today the completion of a $73 million financing led by Hatteras Investment Partners, with participation from new investors ARCH Venture Partners and Moore Strategic Ventures. All existing investors, including Newpath Partners, 8VC and Alexandria Venture Investments, also participated."Myeloid continues to make significant progress across all aspects of our business. We are pioneering the convergence of immunology and RNA science to build a clinical-stage portfolio of products, starting with the significant unmet needs of cancer patients," said Daniel Getts, Ph.D., Chief Executive Officer of Myeloid. "We are pleased that such high-quality investors have joined with us to accelerate this effort." Proceeds from the financing will support the continued clinical development of MT-101, Myeloid's lead cell therapy program in Phase 1/2 for T cell lymphoma, and will accelerate the development of MT-302, a first-in-class TROP2-FcA mRNA-LNP product, into a Phase 1/2 study for TROP2-expressing tumors. Additional in vivo programming candidates are also advancing to the clinic.
Thanks for reading Private Market Roundup! Subscribe for free to receive new posts and support our work.
Deal #6: Carbon accounting firm FLINTpro closes $13.5m Series A
About:
FLINTpro develops natural capital and carbon reporting software that supports organizations throughout their sustainability journey. It simplifies the processing of large and complex data sets, applies the latest scientific and analytical models and runs advanced simulations.
Funding Round Info:
Carbon accounting and land analysis firm FLINTpro has today announced the closure of a $13.5 million Series A funding round which will expand the company’s reach into the North American market. FLINTpro saw its raise supported by lead investor Understorey Ventures alongside new investors Pollination, Persei Venture and existing backers Ananta-OM and Synovia Capital. Though the funds will turbocharge its US push, the company already has an HQ in the region in Fort Collins, Colorado, and works with the likes of the US Forest Service, National Resources Canada, Shell and Yale University.
Back home, FLINTpro’s SaaS platform that pulls together disparate carbon measurements into one visualisation tool is used by the NSW Department of Primary Industries, Grain Producers of South Australia, the Australian Agriculture Company (AACo) and Food Agility Cooperative Research Centre.
These clients tap into the company’s platform to accurately track emissions and measure the validity of their sustainability claims, protecting them from accusations of greenwashing in turn. It also empowers customers to move forward with actionable plans to transform the land they are using.
Deal #7: Hallow Closes $50M in Series C Funding
About:
Hallow is a Catholic prayer and meditation app that hopes to help folks grow closer to God. It helps in finding peace, deepen the relationship with God, and sleep soundly every night. It was founded in 2018 and is based in Chicago, Illinois.
Funding Round Info:
Hallow, a Chicago, IL-based Christian prayer app, raised $50M in Series C funding. The round, which brought the total amount to $105M, was led by Goodwater Capital with participation from Highland Capital, Colin Moran, and existing investors. The company intends to use the funds to expand operations and its business reach. Led by CEO Alex Jones, Hallow provides an app for people to deepen their relationship with God through audio-guided prayers, sleep meditations, Bible readings, meditations, and music. The app has over 10,000 sessions, including a daily Rosary with Mark Wahlberg, daily Gospel, daily saint, novenas, examens, Father Mike Schmitz’s Bible in a Year, Jonathan Roumie’s audio Bible, Bishop Barron’s Sunday Sermons, peaceful Christian music, Gregorian chant, mental health meditations, prayers for kids, and so much more.
Deal #8: Lumeus.ai Launches with $6 Million in Seed Funding
About:
Lumeus is an Agentless Zero Trust Networking technology that enables IT and security teams to integrate connectivity and control from campus to the cloud.
Funding Round Info:
Lumeus.ai, a visibility-first Zero Trust networking platform, has announced its official launch, backed by $6 million in seed funding. The funding round was led by Tola Capital, with participation from pre-seed investors Emergent Ventures and First Rays Ventures. Co-founded by Satish Veerapuneni and Saurabh Jain, Lumeus.ai aims to assist distributed enterprises in modernizing their network security while leveraging their existing infrastructure. Many businesses struggle with comprehensive network visibility and control across branches, campuses, and cloud environments. Last year witnessed a significant surge in ransomware attacks, equivalent to the combined numbers of the previous five years, as reported by Verizon. However, there is a way to mitigate such risks. According to IBM, organizations with mature Zero Trust programs save an average of $1.5 million per breach. This highlights the importance of implementing a Zero Trust approach effectively to minimize the risk of breaches and protect infrastructure. Lumeus.ai, launching today, offers a Universal Zero Trust platform that leverages artificial intelligence and machine learning to enhance visibility from campus to cloud, authorize resource access, and segment network traffic to prevent lateral movement. One of the platform’s key advantages is its seamless integration with existing infrastructure, requiring no agents to be installed on endpoints, enabling organizations to derive value from day one.
Interested in human due diligence services for your investment firm? Visit our website to learn more and connect with us today!